109 related articles for article (PubMed ID: 9839625)
1. Boron neutron capture therapy for glioblastoma: improvement of boron biodistribution by hyaluronidase.
Haselsberger K; Radner H; Pendl G
Cancer Lett; 1998 Sep; 131(1):109-11. PubMed ID: 9839625
[TBL] [Abstract][Full Text] [Related]
2. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
Haselsberger K; Radner H; Pendl G
Neurosurgery; 1996 Aug; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
[TBL] [Abstract][Full Text] [Related]
3. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
Haritz D; Gabel D; Huiskamp R
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
[TBL] [Abstract][Full Text] [Related]
5. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.
Elowitz EH; Bergland RM; Coderre JA; Joel DD; Chadha M; Chanana AD
Neurosurgery; 1998 Mar; 42(3):463-8; discussion 468-9. PubMed ID: 9526978
[TBL] [Abstract][Full Text] [Related]
7. Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope.
Verbakel WF; Sauerwein W; Hideghety K; Stecher-Rasmussen F
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):743-56. PubMed ID: 12573762
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
10. Subcellular boron-10 localization in glioblastoma for boron neutron capture therapy with Na2B12H11SH.
Haselsberger K; Radner H; Gössler W; Schlagenhaufen C; Pendl G
J Neurosurg; 1994 Nov; 81(5):741-4. PubMed ID: 7931621
[TBL] [Abstract][Full Text] [Related]
11. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
[TBL] [Abstract][Full Text] [Related]
12. Case numbers for a randomized clinical trial of boron neutron capture therapy for Glioblastoma multiforme.
Sander A; Wosniok W; Gabel D
Appl Radiat Isot; 2014 Jun; 88():16-9. PubMed ID: 24373823
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view.
Diaz AZ
J Neurooncol; 2003; 62(1-2):101-9. PubMed ID: 12749706
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
15. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
16. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
18. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice.
Ono K; Masunaga S; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):431-6. PubMed ID: 10030272
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy for hepatocellular carcinoma by boric acid-mediated boron neutron capture therapy in a rat model.
Lin SY; Lin CJ; Liao JW; Peir JJ; Chen WL; Chi CW; Lin YC; Liu YM; Chou FI
Anticancer Res; 2013 Nov; 33(11):4799-809. PubMed ID: 24222116
[TBL] [Abstract][Full Text] [Related]
20. Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial.
Hideghéty K; Sauerwein W; Wittig A; Götz C; Paquis P; Grochulla F; Haselsberger K; Wolbers J; Moss R; Huiskamp R; Fankhauser H; de Vries M; Gabel D
J Neurooncol; 2003; 62(1-2):145-56. PubMed ID: 12749710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]